Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (451-460 of 794) with videos related to

Pageof 80
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 2015
Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirementsMarta Ulldemolins, Dolors Soy, Mireia Llaurado-Serra, et al.
Annals of the American Thoracic Society|May 5, 2015
Upper respiratory symptoms worsen over time and relate to clinical phenotype in chronic obstructive pulmonary diseaseArturo Huerta, Gavin C Donaldson, Richa Singh, et al.
The Journal of Infection|April 10, 2019
Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortalityRaúl Méndez, Rosario Menéndez, Isabel Amara-Elori, et al.
BMC Pulmonary Medicine|July 31, 2014
Inflammatory response in mixed viral-bacterial community-acquired pneumoniaSalvador Bello, Elisa Mincholé, Sergio Fandos, et al.
Chest|November 29, 2012
Thrombocytosis is a marker of poor outcome in community-acquired pneumoniaElena Prina, Miquel Ferrer, Otavio T Ranzani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trialAntoni Torres, Javier Garau, Pierre Arvis, et al.
Chest|July 19, 2022
Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation StudyCatia Cilloniz, Logan Ward, Mads Lause Mogensen, et al.
Respiratory Medicine|May 10, 2015
Outcomes in patients with community-acquired pneumonia admitted to the intensive care unitRodrigo Cavallazzi, Timothy Wiemken, Forest W Arnold, et al.
The European Respiratory Journal|January 24, 2012
Community-acquired pneumonia in outpatients: aetiology and outcomesCatia Cillóniz, Santiago Ewig, Eva Polverino, et al.
Archivos De Bronconeumologia|December 4, 2019
Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired PneumoniaIrene Aldás, Rosario Menéndez, Raúl Méndez, et al.
Pageof 80

Showing results (451-460 of 794) with videos related to

Sort By:
Pageof 80
Antimicrobial Agents and Chemotherapy|July 1, 2015
Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirementsMarta Ulldemolins, Dolors Soy, Mireia Llaurado-Serra, et al.
Annals of the American Thoracic Society|May 5, 2015
Upper respiratory symptoms worsen over time and relate to clinical phenotype in chronic obstructive pulmonary diseaseArturo Huerta, Gavin C Donaldson, Richa Singh, et al.
The Journal of Infection|April 10, 2019
Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortalityRaúl Méndez, Rosario Menéndez, Isabel Amara-Elori, et al.
BMC Pulmonary Medicine|July 31, 2014
Inflammatory response in mixed viral-bacterial community-acquired pneumoniaSalvador Bello, Elisa Mincholé, Sergio Fandos, et al.
Chest|November 29, 2012
Thrombocytosis is a marker of poor outcome in community-acquired pneumoniaElena Prina, Miquel Ferrer, Otavio T Ranzani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trialAntoni Torres, Javier Garau, Pierre Arvis, et al.
Chest|July 19, 2022
Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation StudyCatia Cilloniz, Logan Ward, Mads Lause Mogensen, et al.
Respiratory Medicine|May 10, 2015
Outcomes in patients with community-acquired pneumonia admitted to the intensive care unitRodrigo Cavallazzi, Timothy Wiemken, Forest W Arnold, et al.
The European Respiratory Journal|January 24, 2012
Community-acquired pneumonia in outpatients: aetiology and outcomesCatia Cillóniz, Santiago Ewig, Eva Polverino, et al.
Archivos De Bronconeumologia|December 4, 2019
Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired PneumoniaIrene Aldás, Rosario Menéndez, Raúl Méndez, et al.
Pageof 80